Philip James Wealth Mangement’s Gilead Sciences GILD Stock Holding History

Philip James Wealth Mangement’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.64M	Sell	12,976 -731	-5%	-$96.3K	0.18%	71
2026 Q1	$1.91M	Sell	13,707 -1,976	-13%	-$277K	0.22%	65
2025 Q4	$1.92M	Sell	15,683 -230	-1%	-$28K	0.22%	70
2025 Q3	$1.77M	Sell	15,913 -19,050	-54%	-$2.17M	0.21%	72
2025 Q2	$3.88M	Sell	34,963 -11,683	-25%	-$1.24M	0.49%	46
2025 Q1	$5.23M	Sell	46,646 -2,883	-6%	-$297K	0.64%	38
2024 Q4	$4.57M	Sell	49,529 -2,762	-5%	-$249K	0.59%	41
2024 Q3	$4.38M	Buy	+52,291	New	+$3.99M	0.54%	46

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Philip James Wealth Mangement's GILD Position: Q2 2026 in Review

Philip James Wealth Mangement reduced its Gilead Sciences (GILD) stake by 5.3% in Q2 2026, selling an estimated $96.3K and leaving 12,976 shares worth $1.64M. The position accounts for 0.18% of the portfolio, ranked #71.

Philip James Wealth Mangement first reported a position in GILD in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.23M in Q1 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Philip James Wealth Mangement held 12,976 shares of Gilead Sciences worth $1.64M as of Q2 2026.
Philip James Wealth Mangement sold 731 Gilead Sciences shares in Q2 2026, an estimated $96.3K.
Gilead Sciences made up 0.18% of Philip James Wealth Mangement's portfolio in Q2 2026, its #71 holding.
Philip James Wealth Mangement first reported a position in Gilead Sciences in Q3 2024 and has held it in 8 quarters since.
Philip James Wealth Mangement's Gilead Sciences position peaked at $5.23M in Q1 2025.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Philip James Wealth Mangement's 13F filing for Q2 2026, filed 27 Jul 2026.